Amorepacific Vital Beautie Unveils Super Collagen PDRN for Post-Treatment Care
Amorepacific's Vital Beautie brand introduced Super Collagen PDRN, an ingestible supplement. The company positions it for at-home after-care following professional beauty treatments, targeting international K-beauty consumers.
New Ingestible Supplement Targets Post-Treatment Care
Amorepacific's inner beauty brand, Vital Beautie, launched Super Collagen PDRN, an ingestible supplement. The company positions this product for at-home after-care. It targets consumers undergoing professional beauty treatments. Amorepacific states it developed Super Collagen PDRN with dermatologists. The product draws on Amorepacific's skin research expertise.
Super Collagen PDRN uses a dual-format formulation. This includes a PDRN tablet and a liquid collagen component. The launch shows Amorepacific's push into the intersection of inner beauty and professional aesthetics.
Key Ingredients and Formulation Details
The PDRN tablet contains 100 mg of salmon-derived PDRN. It also incorporates hyaluronic acid and glutathione. The liquid component delivers 6,000 mg of low-molecular-weight collagen. Amorepacific states this collagen uses its proprietary AP Collagen Enzyme Hydrolyzed Peptides.
The formula further includes red orange complex, grape seed extract, and vitamin C. Vital Beautie's claims for the supplement focus on supporting skin after aesthetic procedures. This dual-format approach aims to provide comprehensive support for consumers.
Strategic Partnership for International Reach
Vital Beautie supports the launch through a partnership with Gangnam Unni. This Korean medical beauty platform helps position the supplement. Amorepacific describes Super Collagen PDRN as an "edible after-care routine." This strategy targets international consumers who undergo K-beauty procedures. The collaboration with Gangnam Unni provides Amorepacific with a route.
It aims to introduce its ingestible beauty portfolio to consumers already engaged with Korea's medical aesthetics sector. This extends the beauty treatment process beyond clinics into daily at-home routines.
Implications for Asia's Beauty Sector
This product launch demonstrates Amorepacific's strategy to capture revenue. It targets consumers seeking continued care post-professional treatments. For other Asian beauty brands, this reveals a growing market segment. Companies may consider developing ingestible solutions. These products could complement clinic-based aesthetic services.
The partnership with Gangnam Unni also provides a model. It shows how to reach international consumers engaged with Korea's medical aesthetics sector. This approach offers a pathway for other companies to expand their ingestible beauty portfolios and extend brand presence in post-treatment care.
Three newsletters, one newsroom.
The Beauty Brief delivers Asia's beauty week every Monday. Regulatory Radar tracks the rule changes that move markets. Trend Pulse decodes what consumers want next. All free to start.
